We knocked down FZD6 in multiple prostate cancer cell lines and prostate cancer patient-derived xenograft models and demonstrated that knocking down FZD6 suppresses prostate cancer growth in vitro and in vivo and attenuates the DNA damage repair process. Here, FZD6 is linked to prostate cancer.